Cytoplasmic induction and over‐expression of cyclooxygenase‐2 in human prostate cancer: implications for prevention and treatment

No abstract is available for this paper.

• Publication year

  2000

• Venue

  BJU International

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1464-410x.2000.00867.xPMID 11069387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Over‐expression of cyclooxygenase‐2 in human prostate adenocarcinoma

  2000cited by this paper
• Cyclooxygenase-2 expression in human esophageal carcinoma.

  1999cited by this paper
• Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention.

  1999cited by this paper
• Induction of prostaglandin G/H synthase-2 in a canine model of spontaneous prostatic adenocarcinoma.

  1999cited by this paper
• Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.

  1999cited by this paper
• Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.

  1999cited by this paper
• Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.

  1998cited by this paper
• Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

  1998cited by this paper
• Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398.

  1998cited by this paper
• Effect of hormonal status on the expression of the cyclooxygenase 1 and 2 genes and prostaglandin synthesis in rat mammary glands.

  1998cited by this paper
• Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

  1998cited by this paper
• Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

  1998cited by this paper
• Non‐steroidal anti‐inflammatory drugs and prostate cancer progression

  1998cited by this paper
• NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.

  1998cited by this paper
• The effect of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase 1 and 2 and levels of p21ras in rat mammary glands.

  1998cited by this paper
• Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.

  1997cited by this paper
• Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells.

  1997cited by this paper
• Molecular and cellular biology of prostate cancer

  1997cited by this paper
• Expression of cyclooxygenase-2 in human gastric carcinoma.

  1997cited by this paper
• Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

  1997cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• NSAID use and decreased risk of gastrointestinal cancers.

  1996cited by this paper
• Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Prostaglandin endoperoxide H synthases-1 and -2.

  1996cited by this paper
• Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

  1995cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: Effects of fatty acids and cyclooxygenase inhibitors

  1994cited by this paper
• Dietary fat, fatty acids and prostate cancer

  1992cited by this paper
• Bioactivation of xenobiotics by prostaglandin H synthase.

  1991cited by this paper
• Relevance of fatty acids and eicosanoids to clinical and preventive medicine.

  1986cited by this paper

• Synergism of Specific Maca Phenotypes (Lepidium peruvianum) in Combination with Saw Palmetto (Serenoa repens) Extract for Chemoprevention of Prostate Cancer as Determined in In Vitro Cytotoxicity Assays on Human Epithelial and Prostate Cancer Cells

  2024cites this paper
• Causal inference between rheumatoid arthritis and prostate cancer

  2023cites this paper
• Research Progress on the Relationship between Cox Pathway and Prostate Cancer

  2023cites this paper
• The tumor microenvironment and immune targeting therapy in pediatric renal tumors

  2022cites this paper
• Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.

  2021cites this paper
• The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms

  2021cites this paper
• Why exercise has a crucial role in cancer prevention, risk reduction and improved outcomes.

  2021cites this paper
• The multiple effects of aspirin in prostate cancer patients.

  2020cites this paper
• Comparative Approach to the Temporo-Spatial Organization of the Tumor Microenvironment

  2019cites this paper
• Effects of miR-129-3p on biological functions of prostate cancer cells through targeted regulation of Smad3

  2019cites this paper
• New insights into the cellular lipid cascade using infrared microspectroscopy

  2019cites this paper
• If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease

  2018cites this paper
• The impact of celecoxib on outcomes in advanced prostate cancer patients undergoing androgen deprivation therapy.

  2018cites this paper
• Exploring the preventive effect of physical activity on prostate cancer-induced testicular dysfunction

  2018cites this paper
• Endocannabinoid metabolism : the impact of inflammatory factors and pharmacological inhibitors

  2018cites this paper
• Prognostic and Clinic-Pathological Significances of SCF and COX-2 Expression in Inflammatory and Malignant Prostatic Lesions

  2018cites this paper
• phytochemicalsin cancer management

  2017cites this paper
• NSAID Induction of p75 in the Prostate: A Suppressor of Growth and Cell Migration Via the p38 MAPK Pathway

  2017cites this paper
• Evaluation of the Celecoxib Effect against Radiotherapy Induced Acute Toxicities in the Patients with Prostate Cancer Compared with Placebo Group

  2017cites this paper
• Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells

  2017cites this paper
• Radiation Oncology 4-10-2012 alpha ( V ) beta ( 6 ) integrin expression is induced in the POET and Pten ( pc-/-) mouse models of prostatic inflammation and prostatic adenocarcinoma

  2017cites this paper
• Immunohistochemical Study of Cyclooxygenase-2 Expression in Prostate Carcinoma: It’s Relation with Apoptosis and Angiogenesis

  2016cites this paper
• Exercise-induced biochemical changes and their potential influence on cancer: a scientific review

  2016cites this paper
• Role of Macrophages in the Development of Castration-Resistant Prostate Cancer

  2016cites this paper
• Predictive value of cyclooxygenase-2 over expression for identifying prostate cancer from benign prostatic hyperplasia in prostate biopsy specimens.

  2016cites this paper
• The association between regular use of aspirin and the prevalence of prostate cancer

  2016influential citation
• Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity

  2015cites this paper
• High expression of cyclooxygenase-2 in high gradehuman prostate adenocarcinoma

  2015cites this paper
• Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed.

  2015cites this paper
• High Expression of Cyclooxygenase-2 in High Grade Human Prostate Adenocarcinoma (Pengekspresan Tinggi Siklooksigenase-2 dalam Adenokarsinoma Prostat Manusia Gred Tinggi)

  2015cites this paper
• Aspirin use decreases the risk of prostate cancer recurrence after post-prostatectomy radiotherapy

  2015cites this paper
• AMACR versus COX-2 expression in benign prostatic hyperplasia and prostatic adenocarcinoma: a comparative study

  2015cites this paper
• Factors affecting platinum sensitivity in cervical cancer.

  2015cites this paper
• Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study

  2014cites this paper
• Immunohistochemical Evaluation of COX-1 and COX-2 Expression in Keloid and Hypertrophic Scar

  2014cites this paper
• Essential micro nutrient testing – pros and cons – A review of the international literature . Professor

  2014cites this paper
• Cyclooxygenase‐2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice

  2014cites this paper
• Metal-based anticancer agents: targeting androgen-dependent and androgen-independent prostate and COX-positive pancreatic cancer cells by phenanthrenequinone semicarbazone and its metal complexes

  2013cites this paper
• 6-chloro-7-methyl-3', 4'-dimethoxyflavone - a potent selective COX-2 inhibitor.

  2013cites this paper
• Avaliação das atividades mutagênica, pró-inflamatória e estrogênica de Machaerium hirtum e Crotalaria pallida

  2013cites this paper
• Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model

  2013cites this paper
• Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis.

  2013cites this paper
• The effect of combined therapy with tamsulosin hydrochloride and meloxicam in patients with benign prostatic hyperplasia symptoms and impact on nocturia and sleep quality.

  2013cites this paper
• Association between the 8473T>C Polymorphism of PTGS2 and Prostate Cancer Risk: A Metaanalysis Including 24,716 Subjects

  2013cites this paper
• Relationship among expression of basic-fibroblast growth factor, MTDH/astrocyte elevated gene-1, adenomatous polyposis coli, matrix metalloproteinase 9,and COX-2 markers with prognostic factors in prostate carcinomas.

  2013cites this paper
• ExpressionandSignificanceofMicrosomalProstaglandin Synthase-1(mPGES-1)andBeclin-1intheDevelopmentof ProstateCancer

  2012cites this paper
• Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis

  2012cites this paper
• Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study

  2012cites this paper
• Entzündungshemmende Medikamente und Prostatakarzinom: Aktueller Stand der Evidenz

  2012cites this paper
• Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy.

  2012cites this paper
• Oxidative Stress in Prostate Cancer

  2012cites this paper
• α(V)β(6) integrin expression is induced in the POET and Pten(pc-/-) mouse models of prostatic inflammation and prostatic adenocarcinoma.

  2012cites this paper
• [Anti-inflammatory drugs and prostatic carcinoma: current state of evidence].

  2012cites this paper
• Expression and significance of microsomal prostaglandin synthase-1 (mPGES-1) and Beclin-1 in the development of prostate cancer.

  2012cites this paper
• Entzündungshemmende Medikamente und Prostatakarzinom: Aktueller Stand der Evidenz

  2012cites this paper
• Meta-analysis of epidemiological studies demonstrates significant association of PTGS2 polymorphism rs689470 and no significant association of rs20417 with prostate cancer.

  2012cites this paper
• Treatment of men with rising prostate-specific antigen levels following radical prostatectomy

  2011cites this paper
• Genetic Polymorphisms in Inflammation Pathway Genes and Prostate Cancer Risk

  2011cites this paper
• Association of Inflammation Genes with Prostate Cancer 1 Genetic Polymorphisms in Inflammation Pathway Genes and Prostate Cancer Risk

  2011cites this paper
• NITROGEN OXIDE RELEASING PRODRUGS AS ANTIINFLAMMATORY, ANTICANCER AND CARDIOPROTECTIVE AGENTS

  2011cites this paper
• The Angiogenic Switch for Vascular Endothelial Growth Factor-A and Cyclooxygenase-2 in Prostate Carcinoma: Correlation with Microvessel Density, Androgen Receptor Content and Gleason Grade

  2011cites this paper
• Cyclooxygenase-2 Expression in Animal Cancers

  2011cites this paper
• NSAID Induction of p75NTR in the Prostate: A Suppressor of Growth and Cell Migration Via the p38 MAPK Pathway

  2011cites this paper
• Dietary Chemoprevention Studies in Preclinical Models of Prostate Cancer: Bioactive Lipids and Vitamin D

  2010cites this paper
• Determinación de la expresión de la ciclooxigenasa-2 (COX-2) en tejidos con cáncer de próstata e hiperplasia prostática benigna

  2010cites this paper
• Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer

  2010cites this paper
• UNIVERSIDADE FEDERAL DE GOIÁS PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA TROPICAL

  2010cites this paper
• Hospitalization for osteoarthritis and prostate cancer specific mortality among Swedish men with prostate cancer.

  2010cites this paper
• Atorvastatin and Celecoxib in Combination Inhibits the Progression of Androgen-Dependent LNCaP Xenograft Prostate Tumors to Androgen Independence

  2010cites this paper
• Evaluation of the Relationship between Prostate Cancer and Serum Inflammation Markers

  2010cites this paper
• NEOPLASIA INTRA-EPITELIAL PROSTÁTICA: ASPECTOS MORFOLÓGICOS E MOLECULARES

  2010cites this paper
• Use of nonsteroidal anti‐inflammatory drugs and prostate cancer risk: A meta‐analysis

  2010cites this paper
• Possible Benefits of Curcumin Regimen in Combination With Taxane Chemotherapy for Hormone-Refractory Prostate Cancer Treatment

  2010cites this paper
• Cyclooxigenase-2 (COX-2) expression determination in prostate cancer and benign prostatic hyperplasia tissue

  2010cites this paper
• Expression of E-Cadherin, Cox-2, P53 and BCL-2 in Prostate Carcinomas: Correlation with Tumor Differentiation and Metastatic Potential

  2010cites this paper
• Essential micro nutrient testing – pros and cons

  2010cites this paper
• Studies on the pathogenesis and management of prostate carcinoma in dogs

  2009cites this paper
• TITLE: Induction of the p75NTR by Aryl Propionic Acids in Prostate Cancer Cells

  2009cites this paper
• Cyclooxygenase-2 in Cancer and Angiogenesis

  2009cites this paper
• Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer

  2009cites this paper
• Modeling of cyclooxygenase-2 and 5-lipooxygenase inhibitory activity of apoptosis-inducing agents potentially useful in prostate cancer chemotherapy: Derivatives of diarylpyrazole

  2009cites this paper
• A randomised double‐blind phase II study of lifestyle counselling and salicylate compounds in patients with progressive prostate cancer

  2009cites this paper
• Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies.

  2009cites this paper
• Cyclooxygenase 2 expression in soft tissue leiomyosarcoma.

  2009cites this paper
• Prolonging androgen sensitivity in prostate cancer – a role for COX inhibitors?

  2009cites this paper
• Inflammation and Prostatic Carcinogenesis - a morphological study of the human prostate

  2008cites this paper
• Aberrant Activation of Arachidonic Acid and Eicosanoid Pathways-Targets for Treating Prostate Cancer

  2008cites this paper
• Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression.

  2008cites this paper
• Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells.

  2008cites this paper
• Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer.

  2008cites this paper
• Androgen Receptor in Prostate Cancer Progression

  2008cites this paper
• Chemoprevention of prostate cancer: agents, studies and future prospects

  2008cites this paper
• Sexually Transmissible Infections and Prostate Cancer Risk

  2008cites this paper
• Influence of Gestational Age on the Vasodilatory Response of Serotonin in Human Umbilical Arteries Perfused in vitro

  2008cites this paper
• Roles of Eicosanoids in Prostate Cancer.

  2008cites this paper
• Analysis of Cox-2 expression in Wilms' tumor.

  2008cites this paper
• WHAT IS THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER?

  2007cites this paper
• Non-steroidal anti-inflammatory drugs in the treatment of genitourinary malignancies: focus on clinical data

  2007cites this paper
• Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.

  2007cites this paper
• [Prognosis and predictive factors of prostate cancer in the prostatic biopsy].

  2007cites this paper